Additional Information

This CME activity was developed for oncologists, thoracic surgeons, radiologists and other medical professionals who assess, counsel, and treat lung cancer patients

Program Faculty
Thomas J. Lynch, Jr., MD, Chief Oncology/ Hematology, MGH Cancer Center, Armin Ernst, MD, FCCP, Chief, Interventional Pulmonology, Beth Israel Deaconess Medical Center, Michael Lanuti, MD, Department of Thoracic Surgery, Massachusetts General Hospital, Damian E. Dupuy, MD, Department of Diagnostic Imaging, Brown University, Christopher G. Azzoli, MD, Thoracic Oncology Service, Memorial Sloan-Kettering Cancer Center, Rebecca Suk Heist, MD, MPH, Department of Oncology, Massachusetts General Hospital Cancer Center, and David H. Harpole, Jr., MD, Chief, Division of Surgery, Duke University Medical Center.

The CME activity is no longer active..

Statement of Need
Treating early-stage lung cancer is especially challenging, as patients often present while they still feel healthy, and it can be difficult to assess when the benefits of initiating treatment will outweigh the negative effects of intervention.  Medical professionals who counsel and treat patients with early-stage disease need to be aware of the most current data and recommendations for assessing and determining the timing and course of treatment for these patients.

Educational Grant Support
Supported by educational grants from Genentech and sanofi-aventis, U.S.

Sponsorship
CME sponsorship was provided by InforMEDical Communications, Inc.